Understanding When to discontinue NEUPOGEN?
•
4 min read
Over 2% of patients receiving NEUPOGEN at higher doses during myelosuppressive chemotherapy have experienced excessive white blood cell counts. For patient safety and effective treatment, knowing **when to discontinue NEUPOGEN?** is crucial and depends heavily on the specific clinical indication and blood cell count monitoring.
